NEU 6.41% $15.27 neuren pharmaceuticals limited

Neuren Media and Analyst Coverage, page-1309

  1. 956 Posts.
    lightbulb Created with Sketch. 331
    The more we carve off indications for 2591, the less attractive we become for a BP takeover in my view.

    Not my preferred course of action.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.